Skip to main content
Top
Published in: BMC Ophthalmology 1/2020

Open Access 01-12-2020 | Case report

Peters plus syndrome and Chorioretinal findings associated with B3GLCT gene mutation - a case report

Authors: Ye Elaine Wang, Dhariana Acon Ramirez, Ta Chen Chang, Audina Berrocal

Published in: BMC Ophthalmology | Issue 1/2020

Login to get access

Abstract

Background

Peters plus syndrome (PPS) is a combination of congenital Peters anomaly and systemic abnormalities. It is inherited most commonly in an autosomal recessive pattern with homozygous B3GLCT mutations. Ocular findings consist predominantly anterior segment abnormalities without posterior segment involvement.

Case presentation

In this presentation, we report a case of PPS with homozygous pathogenic variant in B3GLCT who presented with classic anterior segment findings, systemic abnormalities, as well as atypical bilateral chorioretinal atrophy. The chorioretinal findings were characterized with spectral-domain optical coherence tomography.

Conclusions

Our report expands the phenotypic descriptions of PPS by characterizing posterior segment findings.
Literature
1.
go back to reference Maillette de Buy Wenniger-Prick, L.J. And R.C. Hennekam, The Peters’ plus syndrome: a review. Ann Genet, 2002. 45(2): p. 97–103.CrossRef Maillette de Buy Wenniger-Prick, L.J. And R.C. Hennekam, The Peters’ plus syndrome: a review. Ann Genet, 2002. 45(2): p. 97–103.CrossRef
2.
go back to reference Lesnik Oberstein SA, et al. Peters plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. Am J Hum Genet. 2006;79(3):562–6.CrossRef Lesnik Oberstein SA, et al. Peters plus syndrome is caused by mutations in B3GALTL, a putative glycosyltransferase. Am J Hum Genet. 2006;79(3):562–6.CrossRef
3.
go back to reference van Schooneveld MJ, et al. Peters'-plus: a new syndrome. Ophthalmic Paediatr Genet. 1984;4(3):141–5.CrossRef van Schooneveld MJ, et al. Peters'-plus: a new syndrome. Ophthalmic Paediatr Genet. 1984;4(3):141–5.CrossRef
4.
go back to reference Heon E, et al. Peters' anomaly. The spectrum of associated ocular and systemic malformations. Ophthalmic Paediatr Genet. 1992;13(2):137–43.CrossRef Heon E, et al. Peters' anomaly. The spectrum of associated ocular and systemic malformations. Ophthalmic Paediatr Genet. 1992;13(2):137–43.CrossRef
5.
go back to reference Cavuoto KM, Chang TC. Mobile Retrolental cyst in a child with Peters plus syndrome. JAMA Ophthalmol. 2016;134(10):e162125.CrossRef Cavuoto KM, Chang TC. Mobile Retrolental cyst in a child with Peters plus syndrome. JAMA Ophthalmol. 2016;134(10):e162125.CrossRef
6.
go back to reference Reis LM, et al. Mutation analysis of B3GALTL in Peters plus syndrome. Am J Med Genet A. 2008;146A(20):2603–10.CrossRef Reis LM, et al. Mutation analysis of B3GALTL in Peters plus syndrome. Am J Med Genet A. 2008;146A(20):2603–10.CrossRef
7.
go back to reference Weh E, et al. Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes. Clin Genet. 2014;86(2):142–8.CrossRef Weh E, et al. Novel B3GALTL mutations in classic Peters plus syndrome and lack of mutations in a large cohort of patients with similar phenotypes. Clin Genet. 2014;86(2):142–8.CrossRef
8.
go back to reference Heinonen TY, et al. Murine ortholog of the novel glycosyltransferase, B3GTL: primary structure, characterization of the gene and transcripts, and expression in tissues. DNA Cell Biol. 2006;25(8):465–74.CrossRef Heinonen TY, et al. Murine ortholog of the novel glycosyltransferase, B3GTL: primary structure, characterization of the gene and transcripts, and expression in tissues. DNA Cell Biol. 2006;25(8):465–74.CrossRef
9.
go back to reference Vasudevan D, et al. Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism. Curr Biol. 2015;25(3):286–95.CrossRef Vasudevan D, et al. Peters plus syndrome mutations disrupt a noncanonical ER quality-control mechanism. Curr Biol. 2015;25(3):286–95.CrossRef
10.
go back to reference Hess D, et al. Peters plus syndrome is a new congenital disorder of glycosylation and involves defective omicron-glycosylation of thrombospondin type 1 repeats. J Biol Chem. 2008;283(12):7354–60.CrossRef Hess D, et al. Peters plus syndrome is a new congenital disorder of glycosylation and involves defective omicron-glycosylation of thrombospondin type 1 repeats. J Biol Chem. 2008;283(12):7354–60.CrossRef
11.
go back to reference Heinonen TY, Maki M. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats. Ann Med. 2009;41(1):2–10.CrossRef Heinonen TY, Maki M. Peters'-plus syndrome is a congenital disorder of glycosylation caused by a defect in the beta1,3-glucosyltransferase that modifies thrombospondin type 1 repeats. Ann Med. 2009;41(1):2–10.CrossRef
Metadata
Title
Peters plus syndrome and Chorioretinal findings associated with B3GLCT gene mutation - a case report
Authors
Ye Elaine Wang
Dhariana Acon Ramirez
Ta Chen Chang
Audina Berrocal
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2020
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01380-6

Other articles of this Issue 1/2020

BMC Ophthalmology 1/2020 Go to the issue